ATRA vs MSFT: Which Stock is Better?
Side-by-side comparison of Atara Biotherapeutics Inc and Microsoft Corp in 2026
ATRA
Atara Biotherapeutics Inc
$4.32
MSFT
Microsoft Corp
$454.79
Key Metrics Comparison
| Metric | ATRA | MSFT | Winner |
|---|---|---|---|
| Market Cap | $32.73M | $3.38T | MSFT |
| P/E Ratio | 1.59 | 36.30 | ATRA |
| EPS (TTM) | $2.86 | $13.70 | MSFT |
| Revenue Growth | -0.9% | 14.9% | MSFT |
| Gross Margin | 46.8% | 68.8% | MSFT |
Analyze ATRA
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ATRA or MSFT a better investment?
Comparing ATRA and MSFT: Atara Biotherapeutics Inc has a market cap of $32.73M while Microsoft Corp has $3.38T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ATRA and MSFT?
ATRA (Atara Biotherapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ATRA or MSFT?
Based on P/E ratios, ATRA trades at a lower multiple (1.6x vs 36.3x).
Which is growing faster: ATRA or MSFT?
MSFT has higher revenue growth at 14.9% vs -0.9% for ATRA.
Which company is more profitable: ATRA or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 46.8% for ATRA.
Which is the larger company: ATRA or MSFT?
Microsoft Corp (MSFT) is larger with a market cap of $3.38T compared to $32.73M for ATRA.
Should I buy ATRA or MSFT in 2026?
Both ATRA and MSFT have investment merit. ATRA trades at $4.32 while MSFT trades at $454.79. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ATRA and MSFT stock?
Key differences: Market Cap ($32.73M vs $3.38T), P/E Ratio (1.6x vs 36.3x), Revenue Growth (-0.9% vs 14.9%), Gross Margin (46.8% vs 68.8%).